Rise Advisors, LLC Solid Biosciences Inc. Transaction History

Rise Advisors, LLC

  • $220 Million
  • Q1 2025

A detailed history of Rise Advisors, LLC transactions in Solid Biosciences Inc. stock. As of the latest transaction made, Rise Advisors, LLC holds 95 shares of SLDB stock, worth $266. This represents 0.0% of its overall portfolio holdings.

Number of Shares
95
Holding current value
$266
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025
BUY
$2.88 - $6.47 $273 - $614
95 New
95 $0

Others Institutions Holding SLDB

# of Institutions
4
Shares Held
568
Call Options Held
0
Put Options Held
0
View Full List

About Solid Biosciences Inc.

SLDB Quotes by TradingView
  • Ticker SLDB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 7,533,080
  • Market Cap $21.1M
  • Description
  • Solid Biosciences Inc. engages in developing therapies for duchenne muscular dystrophy in the United States. The company's lead product candidate is SGT-001, a gene transfer candidate, which is in a Phase I/II clinical trial to drive functional dystrophin protein expression in patients' muscles; and SGT-003, a ext-generation gene transfer candid...
More about SLDB
Track This Portfolio

Track Rise Advisors, LLC Portfolio

Follow Rise Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rise Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rise Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email